The Oncologist, Vol. 11, No. 4, 342-357, April 2006; doi:10.1634/theoncologist.11-4-342
© 2006 AlphaMed Press
Immunotherapy, Monoclonals, and Vaccines |
Chemotherapeutic Approaches for Targeting Cell Death Pathways
M. Stacey Riccia,
Wei-Xing Zongb
a National Cancer Institute and Food and Drug Administration Interagency Oncology Task Force, Bethesda, Maryland, USA;
b Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, USA
Key Words. Chemotherapy • Apoptosis • Necrosis • Autophagy • Senescence • Mitotic catastrophe
Correspondence:
Wei-Xing Zong, Ph.D., Department of Molecular Genetics and Microbiology, Stony Brook University, 128 Life Sciences Building, Stony Brook, New York 11794-5222, USA. Telephone: 631-632-4104; Fax: 631-632-9797; e-mail: wzong{at}notes.cc.sunysb.edu
For several decades, apoptosis has taken center stage as the principal mechanism of programmed cell death in mammalian tissues. It also has been increasingly noted that conventional chemotherapeutic agents not only elicit apoptosis but other forms of nonapoptotic death such as necrosis, autophagy, mitotic catastrophe, and senescence. This review presents background on the signaling pathways involved in the different cell death outcomes. A re-examination of what we know about chemotherapy-induced death is vitally important in light of new understanding of nonapoptotic cell death signaling pathways. If we can precisely activate or inhibit molecules that mediate the diversity of cell death outcomes, perhaps we can succeed in more effective and less toxic chemotherapeutic regimens.
This article has been cited by other articles:

|
 |

|
 |
 
S. Tardito, C. Isella, E. Medico, L. Marchio, E. Bevilacqua, M. Hatzoglou, O. Bussolati, and R. Franchi-Gazzola
The Thioxotriazole Copper(II) Complex A0 Induces Endoplasmic Reticulum Stress and Paraptotic Death in Human Cancer Cells
J. Biol. Chem.,
September 4, 2009;
284(36):
24306 - 24319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. K. Leong, T. S. T. Muhammad, and S. F. Sulaiman
Cytotoxic Activities of Physalis minima L. Chloroform Extract on Human Lung Adenocarcinoma NCI-H23 Cell Lines by Induction of Apoptosis
Evid. Based Complement. Altern. Med.,
June 18, 2009;
(2009)
nep057v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bataller, C. Mendez, J. A. Salas, and J. Portugal
Mithramycin SK modulates polyploidy and cell death in colon carcinoma cells
Mol. Cancer Ther.,
September 1, 2008;
7(9):
2988 - 2997.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Singletary and J. Milner
Diet, Autophagy, and Cancer: A Review
Cancer Epidemiol. Biomarkers Prev.,
July 1, 2008;
17(7):
1596 - 1610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Lefranc, V. Facchini, and R. Kiss
Proautophagic Drugs: A Novel Means to Combat Apoptosis-Resistant Cancers, with a Special Emphasis on Glioblastomas
Oncologist,
December 1, 2007;
12(12):
1395 - 1403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Stevens, G. Liu, S. W. Bremer, K. J. Ye, W. Xu, J. Xu, Y. Sun, G. S. Wu, S. Savasan, S. A. Krawetz, et al.
Mitotic Cell Death by Chromosome Fragmentation
Cancer Res.,
August 15, 2007;
67(16):
7686 - 7694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Olofsson, T. Ueno, Y. Pan, R. Xu, F. Cai, H. van der Kuip, T. E. Muerdter, M. Sonnenberg, W. E. Aulitzky, S. Schwarz, et al.
Cytokeratin-18 Is a Useful Serum Biomarker for Early Determination of Response of Breast Carcinomas to Chemotherapy
Clin. Cancer Res.,
June 1, 2007;
13(11):
3198 - 3206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Choe, Z. Chen, C. M. Klass, X. Zhang, and D. M. Shin
Enhancement of Docetaxel-Induced Cytotoxicity by Blocking Epidermal Growth Factor Receptor and Cyclooxygenase-2 Pathways in Squamous Cell Carcinoma of the Head and Neck
Clin. Cancer Res.,
May 15, 2007;
13(10):
3015 - 3023.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by AlphaMed Press.
|
|